Goldman Sachs’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-4,881
| Closed | -$34K | – | 4326 |
|
|
2018
Q2 | $34K | Buy |
4,881
+1,878
| +63% | +$13.1K | ﹤0.01% | 4093 |
|
|
2018
Q1 | $25K | Buy |
+3,003
| New | +$25K | ﹤0.01% | 4132 |
|
|
2017
Q4 | – | Sell |
-1,448
| Closed | -$17K | – | 4405 |
|
|
2017
Q3 | $17K | Buy |
+1,448
| New | +$17K | ﹤0.01% | 4203 |
|
|
2017
Q1 | – | Sell |
-1,925
| Closed | -$63K | – | 4613 |
|
|
2016
Q4 | $63K | Sell |
1,925
-2,877
| -60% | -$94.2K | ﹤0.01% | 4199 |
|
|
2016
Q3 | $197K | Buy |
4,802
+1,075
| +29% | +$44.1K | ﹤0.01% | 3941 |
|
|
2016
Q2 | $122K | Buy |
3,727
+2,069
| +125% | +$67.7K | ﹤0.01% | 4050 |
|
|
2016
Q1 | $103K | Buy |
+1,658
| New | +$103K | ﹤0.01% | 4022 |
|
|
2015
Q4 | – | Sell |
-2,362
| Closed | -$129K | – | 4702 |
|
|
2015
Q3 | $129K | Sell |
2,362
-961
| -29% | -$52.5K | ﹤0.01% | 4057 |
|
|
2015
Q2 | $365K | Buy |
3,323
+539
| +19% | +$59.2K | ﹤0.01% | 3578 |
|
|
2015
Q1 | $264K | Buy |
2,784
+180
| +7% | +$17.1K | ﹤0.01% | 3726 |
|
|
2014
Q4 | $146K | Sell |
2,604
-503
| -16% | -$28.2K | ﹤0.01% | 4122 |
|
|
2014
Q3 | $225K | Buy |
3,107
+947
| +44% | +$68.6K | ﹤0.01% | 3872 |
|
|
2014
Q2 | $324K | Sell |
2,160
-2,268
| -51% | -$340K | ﹤0.01% | 3630 |
|
|
2014
Q1 | $644K | Buy |
+4,428
| New | +$644K | ﹤0.01% | 3229 |
|